CRISPR Therapeutics AG

Research CRISPR Therapeutics AG (CRSP) on Bullrun: market cap USD 5.43B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRSP
• ExchangeNASDAQ
• CountrySwitzerland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 5.43B
• Financial periodFY2025
• RevenueUSD 3.51M
• Revenue growth-90.6%
• Net income-USD 581.60M
• Free cash flow-USD 345.93M

Valuation Snapshot

latest market cap is USD 5.43B.

About CRISPR Therapeutics AG

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a technology for gene editing which is the process of precisely altering specific sequences of genomic DNA.

Frequently asked questions

What is CRISPR Therapeutics AG's market cap?

CRISPR Therapeutics AG's market capitalization is USD 5.43B.

What does CRISPR Therapeutics AG do?

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.